Table 3 |
|||
|
Knowledge assessment of the HPV vaccine: adjusted proportions of the correct answers by race |
|||
|
Blacks* (95% CI) |
Whites* (95% CI) |
p-value |
|
|
|
|||
|
Have you heard about the HPV vaccine? Answer = Yes |
76.4% (60.1%–87.4%) |
93.3% (84.9%–97.2%) |
0.031 |
|
The HPV vaccine is approved for individuals who have never been infected with HPV Answer = True |
48.8% (33.8%–64.0%) |
81.2% (69.9%–88.9) |
0.004 |
|
Who is eligible for the HPV vaccine? Answer = Females |
63.7% (47.8%–77.1%) |
81.3% (69.2%–89.3%) |
|
|
For which age group is the HPV vaccine recommended? Answer = 9–26 |
63.2% (46.6%–77.2%) |
89.5% (78.5%–95.2%) |
0.012 |
|
The current FDA approved HPV vaccine protects against genital warts and most cervical cancer Answer = True |
20.0% (10.0%–36.1%) |
16.1% (8.1%–29.3%) |
|
|
Once vaccinated women no longer have to be screened (annual pap smears) for cervical cancer Answer = False |
78.9% (63.8%–88.8%) |
91.7% (82.7%–96.3%) |
|
|
|
|||
|
*Proportions adjusted for location, age, education, income, parental status and marital status; p-value shown only when there is a statistically significant difference between Blacks and Whites. |
|||
|
Ragin et al. Infectious Agents and Cancer 2009 4(Suppl 1):S10 doi:10.1186/1750-9378-4-S1-S10 |
|||